Physician

Abhishake Kaapuraala, M.D.

According to 2025 Medicare claims, Abhishake Kaapuraala, M.D. (NPI: 1841456316) practices hospitalist, with the plurality of this provider's patient population coming from Hardin, OH. This provider's primary affiliated billing organization is ACCESS BEHAVIORAL LLC (NPI: 1437463213; TIN: 273082240) and primary practice location at 45420-1833.

Kaapuraala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 172 traditional Medicare patients, billed 1,646 HCPCS/CPT codes, and received $59,929 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,916 prescription claims across 375 beneficiaries totaling $1,268,302 in drug costs, led by Ozempic (Semaglutide). DME data shows 65 claims. Open Payments data shows 51 records totaling $1,101. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $375,526 to $59,929. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $24,366 to $4,427.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	668	36,116	$375,526
2016	645	12,429	$197,889
2017	332	1,135	$81,989
2018	318	1,044	$76,061
2019	282	917	$71,783
2020	580	1,733	$135,348
2021	184	944	$66,333
2022	170	870	$51,747
2023	229	1,107	$67,500
2024	172	1,646	$59,929

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	490	7,173	$533,799
2016	439	4,630	$329,660
2017	206	688	$21,450
2018	243	683	$28,479
2019	200	524	$23,664
2020	213	426	$16,256
2021	166	2,547	$351,743
2022	245	3,667	$593,740
2023	315	4,925	$940,292
2024	375	8,916	$1,268,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	130	573	$46,161
2016	110	549	$50,468
2017	16	138	$13,741
2018	N/R	99	$11,306
2019	N/R	120	$6,902
2020	12	150	$10,158
2021	N/R	151	$17,409
2022	N/R	98	$10,191
2023	N/R	35	$1,290
2024	N/R	65	$3,374

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	54	54	$116
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	58	95	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	92	211	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	99	271	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	87	181	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	145	6,590	$214,305
Farxiga	Dapagliflozin Propanediol	151	8,228	$153,425
Trulicity	Dulaglutide	96	3,282	$109,419
Mounjaro	Tirzepatide	60	2,390	$88,755
Jardiance	Empagliflozin	56	3,284	$63,814

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$1,590
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	20	$1,143
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	22	$517
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	11	$124

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$1,101	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhishake Kaapuraala, M.D.?

Tedicare shows public-source Medicare data for Abhishake Kaapuraala, M.D. (NPI 1841456316), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhishake Kaapuraala, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abhishake Kaapuraala, M.D.?

Abhishake Kaapuraala, M.D. is linked to ACCESS BEHAVIORAL LLC (billing NPI 1437463213) in the available physician profile data.

Does Abhishake Kaapuraala, M.D. have Open Payments data?

Abhishake Kaapuraala, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.